University of Montana, Missoula, Montana, USA.
Jawaharlal Nehru Technological University, Hyderabad, India.
Clin Pharmacol Ther. 2023 Mar;113(3):483-485. doi: 10.1002/cpt.2852. Epub 2023 Jan 29.
Prioritization of diversity, equity, and inclusion in all facets of our work is long overdue for the clinical pharmacology community. Increasing diversity in clinical research will deepen our understanding of nuanced patient populations and help improve all patient outcomes. Fostering an inclusive and diverse workforce will lead to broader perspectives that can better inform critical decisions and create work environments where everyone can thrive. In this call to action, we invite you to join us.
临床药理学领域早就应该把多样性、公平性和包容性放在我们工作的所有方面的优先位置。在临床研究中增加多样性将加深我们对细微差别患者群体的理解，并有助于改善所有患者的治疗效果。培养包容和多元化的员工队伍将带来更广泛的视角，从而能够更好地为关键决策提供信息，并创造一个每个人都能茁壮成长的工作环境。在这个行动呼吁中，我们邀请您加入我们。
